Navigation Links
FDA Warns Against Sale of Sports Supplements in U.S.
Date:4/15/2013

MONDAY, April 15 (HealthDay News) -- Dietary supplements that contain a stimulant called dimethylamylamine (DMAA) pose numerous health risks and are no longer allowed to be sold in the United States, the U.S. Food and Drug Administration has warned.

DMAA -- which is most often used in supplements promising weight loss, muscle-building and improvement of athletic performance -- can increase blood pressure and may lead to cardiovascular problems such as heart attack, shortness of breath and tightening of the chest. The stimulant may be particularly dangerous when used with caffeine, according to the FDA.

The agency has received 60 reports of illnesses and deaths associated with supplements containing DMAA. The incidents included heart problems and nervous system or psychiatric disorders.

However, a report in itself doesn't prove that a product caused a health problem, an agency news release noted.

The FDA sent warning letters to companies that use DMAA in dietary supplements. All but one of the companies have agreed to stop using the ingredient in their products. One company, USPLabs, has not complied. It responded to the warning letter by submitting published studies that the company said challenge the FDA's concerns.

However, the FDA said the studies did not have sufficient information to defend the use of DMAA in dietary supplements. The government agency is finalizing a formal response to USPLabs, according to Daniel Fabricant, director of FDA's division of dietary supplement programs.

As the FDA continues its efforts to get the stimulant off the market, it urges consumers to check labels and avoid any dietary supplements containing DMAA. Consumers need to be aware that the ingredient can be referred to by 10 possible names. These are listed on the FDA's DMAA web page.

More information

The U.S. Food and Drug Administration has more about DMAA.

-- Robert Preidt

SOURCE: U.S. Food and Drug Administration, news release, April 11, 2013


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. DrugRisks Stryker Recall Update: Company Warns Investors as Patients Alleging Injury Ask to Send Lawsuits to Federal Court
2. American Association of Poison Control Centers Warns That Children Act Fast … and So Do Poisons
3. Know Whats in Your Childs Medications, FDA Warns
4. Facebook Likes Leave a Personal Trail, Study Warns
5. Tattoos Can Pose Health Hazards, Doctor Warns
6. Eating Out Can Hurt Heart Health, Expert Warns
7. Law Firm Warns Patients Who Have Received Alleged Defective Smith & Nephew Hip and Knee Replacement Systems
8. Dont Overlook Eating Issues Tied to Autism, Study Warns
9. Beware Fake Flu Treatments, FDA Warns
10. Winter Holds Many Hazards for Seniors, Expert Warns
11. Health Canada Warns on Interaction of Prilosec with Methotrexate: AttorneyOne Informs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Warns Against Sale of Sports Supplements in U.S.
(Date:4/28/2017)... ... 2017 , ... Ushio America proudly introduces the new ... solution for F32T8 fluorescent lamps on most instant-start and programmed-start electronic ballasts so ... lamps utilize the existing electronic ballast, saving labor and maintenance costs. It’s easy ...
(Date:4/28/2017)... Md. (PRWEB) , ... April 28, 2017 , ... ... Association of America (UCAOA) and College of Urgent Care Medicine will host industry ... workshops, sessions and speakers will help those in the industry adapt to the ...
(Date:4/28/2017)... ... April 28, 2017 , ... Researchers at ... ActiGraph’s CentrePoint Data Hub in a sample of participants enrolled in ... activity and sleep monitoring solutions for the global scientific community. The company’s new ...
(Date:4/28/2017)... ... 28, 2017 , ... Rob Lowe is a popular actor that has been ... to an educational purpose as the host of the “Informed” series. The program focuses ... recent episode, the series focuses on thyroid cancer. , Although thyroid cancer is an ...
(Date:4/27/2017)... ... April 27, 2017 , ... Healthcare companies are trying ... will rapidly reject an outdated healthcare executive resume. , “If you’re a healthcare executive ... executive resume and wondering if it’s as ready as you are for a new ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... WOONSOCKET, R.I. , April 20, 2017 /PRNewswire/ ... (NYSE: CVS), today unveiled a new store design ... new assortment of healthier food, health-focused products and ... the store to help customers discover new offerings. ... represent the next evolution of the customer experience ...
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... financial results for the first quarter 2017 after the ... Company,s management team will host a corresponding conference call ... Investors interested in listening to the conference ... domestic callers or (703) 326-3030 for international callers, using ...
Breaking Medicine Technology: